Fighting COVID-19 with Antibody Therapy @RockefellerUniv
Fighting COVID-19 with Antibody Therapy  @RockefellerUniv
Uploaded February 2021 | Updated September 2026, 2 hours ago
The Rockefeller University
Virtual Discussions with Genuine Experts
December 10, 2020

Speakers:
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
The Rockefeller University

Michel C. Nussenzweig, M.D., Ph.D.
Zanvil A. Cohn and Ralph M. Steinman Professor
Laboratory of Molecular Immunology
Investigator, Howard Hughes Medical Institute

Since the onset of the pandemic, immunologist Michel Nussenzweig has been working to deliver new antibody treatments for COVID-19. In this webinar, Dr. Nussenzweig and President Rick Lifton discussed some of the most pressing questions about COVID-19 research and therapeutic discovery. For example, "What is the status of antibody therapies developed at Rockefeller?" and "Can antibody therapies protect against infection?"

Your contributions are vital to COVID-19 research.
To learn more about research at Rockefeller University and to make a gift to the Fund for COVID-19 Research please visit: https://covid-19-research.rockefeller.edu/
Fighting COVID-19 with Antibody TherapyThe Rockefeller Scientist: Alipasha Vaziri, Ph.D.High fat diet increases inflammation in the mouse colonPress briefing for science journalists at The Rockefeller University, Spring 2018Science 101 for Parents: How Epigenetics is Revolutionizing the Understanding of HeredityThe Inside Story: How the Microbiome Influences Communication Between Our Nervous and Immune SystemsLab Profile: Luciano MarraffiniThe Rockefeller Scientist - Mary E. Hatten, Ph.D.Antibody Therapeutics and Pathways to PreventionEmil C. Gotschlich, M.D. - Oral History ExcerptsThe Rockefeller Scientist - Sean F. Brady, Ph.D.Michael W. Young, 2017 Nobel Laureate in Physiology or Medicine
The Rockefeller University |

Fighting COVID-19 with Antibody Therapy

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER